Skip to main content
OpenTrials

Clinical trial condition

Bone Diseases

Explore clinical trials studying Bone Diseases. Study availability and eligibility vary by location and protocol.

5,842 public trials 803 recruiting studies
Refine in advanced search Browse all conditions

Bone Diseases trial results

Completed

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

NCT01709110

Conditions
Back Injuries, Bone Diseases, Bone Diseases, Metabolic, +10 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Laguna Hills, California, United States
View all 103 locations
View Trial Details
Completed

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

NCT01197300

Conditions
Bone Diseases, Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Vancouver, British Columbia, Canada
  • Novartis Investigative Site Ottawa, Ontario, Canada
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Completed

A Study of LY2541546 in Women With Low Bone Mineral Density

NCT01144377

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +3 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bethesda, Maryland, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hvidovre, Denmark
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vejle, Denmark
View Trial Details
Completed

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

NCT01673646

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Developmental, +23 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Toyoake, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kitakyushu, Fukuoka, Japan
View all 27 locations
View Trial Details
Completed

Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis

NCT02750592

Conditions
Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
Locations
  • Novartis Investigative Site Kitakyushu, Fukuoka, Japan
  • Novartis Investigative Site Kita-gun, Kagawa-ken, Japan
  • Novartis Investigative Site Nankoku, Kochi, Japan
  • Novartis Investigative Site Tenri, Nara, Japan
View Trial Details

Related conditions